Bleakley Financial Group’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-2,057
Closed -$464K – 806
2024
Q4
$464K Buy
2,057
+216
+12% +$48.2K 0.01% 646
2024
Q3
$383K Sell
1,841
-10,992
-86% -$2.21M 0.01% 683
2024
Q2
$2.41M Buy
12,833
+232
+2% +$43K 0.07% 250
2024
Q1
$2.33M Sell
12,601
-69
-0.5% -$12.8K 0.07% 269
2023
Q4
$2.3M Sell
12,670
-409
-3% -$70.8K 0.07% 254
2023
Q3
$2.31M Buy
13,079
+229
+2% +$43.1K 0.08% 225
2023
Q2
$2.42M Buy
+12,850
New +$2.43M 0.08% 225

Other funds holding MSGS

Bleakley Financial Group's MSGS Position: Q1 2025 in Review

Bleakley Financial Group sold out of Madison Square Garden (MSGS) in Q1 2025, closing a stake of 2,057 shares — an estimated $464K sold.

Bleakley Financial Group first reported a position in MSGS in Q2 2023 and held it in 7 quarters. The position peaked at $2.42M in Q2 2023. 342 funds tracked by Wall St. Rank hold MSGS as of Q1 2025.

  • Bleakley Financial Group reported no remaining Madison Square Garden position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 2,057 Madison Square Garden shares in Q1 2025, an estimated $464K.
  • Bleakley Financial Group first reported a position in Madison Square Garden in Q2 2023 and held it in 7 quarters.
  • Bleakley Financial Group's Madison Square Garden position peaked at $2.42M in Q2 2023.
  • 342 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.